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Abstract. 
 
The protein cross-linking enzyme tissue 
transglutaminase binds in vitro with high afﬁnity to ﬁ-
bronectin via its 42-kD gelatin-binding domain. Here 
we report that cell surface transglutaminase mediates 
adhesion and spreading of cells on the 42-kD ﬁbro-
nectin fragment, which lacks integrin-binding motifs. 
Overexpression of tissue transglutaminase increases
its amount on the cell surface, enhances adhesion and 
spreading on ﬁbronectin and its 42-kD fragment, en-
larges focal adhesions, and ampliﬁes adhesion-depen-
dent phosphorylation of focal adhesion kinase. These 
effects are speciﬁc for tissue transglutaminase and are 
not shared by its functional homologue, a catalytic sub-
unit of factor XIII. Adhesive function of tissue trans-
glutaminase does not require its cross-linking activity 
but depends on its stable noncovalent association with 
integrins. Transglutaminase interacts directly with mul-
tiple integrins of 
 
b
 
1 and 
 
b
 
3 subfamilies, but not with 
 
b
 
2 
integrins. Complexes of transglutaminase with integrins 
are formed inside the cell during biosynthesis and accu-
mulate on the surface and in focal adhesions. Together 
our results demonstrate that tissue transglutaminase 
mediates the interaction of integrins with ﬁbronectin, 
thereby acting as an integrin-associated coreceptor to 
promote cell adhesion and spreading.
Key words: adhesion • integrins • tissue transgluta-
minase • ﬁbronectin • focal adhesions
 
Introduction
 
Transglutaminases are a family of Ca
 
11
 
-dependent en-
zymes that mediate covalent cross-linking of proteins by
forming amide bonds between glutamines and 
 
e
 
-amino
groups of lysine residues (Folk, 1980). At least five trans-
glutaminase genes were identified in vertebrates. Among
them, tissue transglutaminase (tTG)
 
1
 
 is the only family
member expressed in a wide variety of tissues and cell
types (Thomazy and Fesus, 1989). Although tTG cross-
links several intracellular and extracellular proteins in
vitro, its function(s) remain poorly understood. Previous
work implicated tTG in programmed cell death (Oliverio
et al., 1997). Elevated tTG expression and enzymatic activ-
ity in a number of cell types inhibits proliferation and ac-
companies cell differentiation and senescence (Aeschli-
mann et al., 1993). Some data suggest tTG involvement in
regulation of tumor growth and metastasis (Johnson et al.,
1994; van Groningen et al., 1995). A variety of growth fac-
tors, cytokines, and retinoids upregulate tTG expression in
many cell lines (Davies et al., 1985; George et al., 1990;
Nagy et al., 1996; Ritter and Davies, 1998). The GTP-bind-
ing protein Gh, which mediates intracellular signaling by
the 
 
a
 
1B adrenergic receptor, was identified as tTG, indi-
cating that tTG has signaling functions apart from its enzy-
matic activity (Nakaoka et al., 1994). A potential signifi-
cance of tTG in neurodegenerative diseases stems from
the fact that this enzyme polymerizes proteins with poly-
glutamine expansions such as huntingtin (Kahlem et al.,
1996, 1998), and binds to and cross-links 
 
b
 
-amyloid pep-
tides in vitro (Dudek and Johnson, 1994). Transgluta-
minase activity has been shown to increase in Alzheimer’s
disease brain (Johnson et al., 1997).
tTG localizes primarily in the cytoplasm, with a small
part of its intracellular pool present in the nucleus (Lesort
et al., 1998). In addition, some amounts of the enzyme are
present on the cell surface and in the extracellular matrix
(ECM) (Upchurch et al., 1991; Aeschlimann et al., 1995;
Verderio et al., 1998). Since there is no leader sequence in
tTG, it remains unknown how it is exported to the cell sur-
face. tTG was shown to bind several ECM proteins, in-
cluding fibronectin (Fn) (Bowness et al., 1987; Achyuthan
et al., 1988; Turner and Lorand, 1989). tTG interacts in
vitro with a 42-kD gelatin-binding domain of Fn that con-
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sists of modules I
 
6
 
II
 
1,2
 
I
 
7-9
 
 and lacks integrin-binding motifs
(see Fig. 1 A; Radek et al., 1993). One well-documented
property of cell surface tTG is the ability to cross-link
ECM proteins, such as Fn, fibrinogen, osteopontin, and
laminin–nidogen complexes (Aeschlimann and Paulsson,
1991; Martinez et al., 1994; Kleman et al., 1995; Kaartinen
et al., 1997). It was suggested that processing of Fn by sur-
face tTG on endothelial cells serves to stabilize the ECM
and anchor cells to the basement membranes (Martinez
et al., 1994).
Emerging evidence suggests a role for tTG in cell adhe-
sion. Overexpression of tTG in fibroblasts increased cell
spreading and reduced susceptibility to detachment with
trypsin (Gentile et al., 1992). Reduced expression of tTG
led to diminished cell adhesion and spreading of endothe-
lial cells, and a tTG-inactivating mAb reduced cell adhe-
sion and spreading on Fn (Jones et al., 1997; Verderio et al.,
1998). Additionally, tTG was shown to stabilize melanoma
cell adhesion under laminar flow (Menter et al., 1991). So
far, there is no explanation for the apparent involvement
of tTG in cell adhesion. Here we show that cell surface
tTG (a) interacts with integrins of the 
 
b
 
1 and 
 
b
 
3 subfami-
lies, (b) mediates their association with 42-kD gelatin-
binding domain of Fn that lacks integrin-binding sites, and
(c) potentiates integrin signaling. tTG-dependent stimula-
tion of cell adhesion and spreading does not require its en-
zymatic activity and is not shared by its functional homo-
logue, a catalytic subunit of blood coagulation factor XIII
(FXIIIa), indicating an unconventional role of this enzyme
in cell adhesion. Together, our data demonstrate a novel
function of cell surface tTG as an integrin-associated ad-
hesion coreceptor for Fn.
 
Materials and Methods
 
cDNAs, Antibodies, and Fn Fragments
 
A cDNA encoding human endothelial tTG (Gentile et al., 1991) was pro-
vided by Dr. P. Davies (University of Texas, Houston, TX). A cDNA for
human placental FXIIIa (Grundmann et al., 1986) was obtained from Dr.
E. Davie (University of Washington, Seattle, WA). Rabbit polyclonal an-
tibodies against guinea pig liver tTG and human red blood cell tTG were
provided by Dr. P. Birckbichler (University of Oklahoma, Oklahoma
City, OK) and Dr. L. Lorand (Northwestern University, Chicago, IL), re-
spectively, and were described previously (Gentile et al., 1991; Jeong et al.,
1995; Jones et al., 1997; Verderio et al., 1998). mAbs CUB7402 and TG100
against tTG were obtained from NeoMarkers. An NH
 
2
 
-terminal tTG do-
main tTG
 
1-165
 
 was expressed in pGEX-2T plasmid (Amersham Pharmacia
Biotech) in 
 
E
 
.
 
 coli 
 
as glutathione 
 
S
 
-transferase fusion protein and purified
on glutathione–Sepharose, followed by cleavage with thrombin. 42-kD
gelatin-binding (I
 
6
 
II
 
1-2
 
I
 
7-9
 
) and 110-kD cell-binding (III
 
2-11
 
) proteolytic
fragments of Fn were generated and purified as described (Isaacs et al.,
1989). Rabbit polyclonal antibody against FXIIIa was from Calbiochem
and antibody against FGF receptor FGFR-1 Flg (H-76) was from Santa
Cruz Biotechnology. Antivinculin mAb 7F9 was described earlier (Belkin
et al., 1996). Rhodamine-phalloidin was from Molecular Probes. mAb
25E11 against human 
 
b
 
3 integrin and mAb YFC118.3 against human 
 
b
 
2
integrin were from Chemicon.
 
PCR-based Mutagenesis
 
C
 
277
 
®
 
S tTG mutant was generated by PCR-based mutagenesis and con-
firmed by sequencing.
 
Cell Culture and Transfections
 
WI-38 fibroblasts and human erythroleukemia (HEL) cells were obtained
 
from ATCC and cultured by standard methods. Rat embryonic fibroblasts
REF52 and rat smooth muscle cells PAC-1 were kindly provided by Dr.
K. Burridge (University of North Carolina, Chapel Hill, NC) and Dr. V.E.
Koteliansky (Biogen Inc., Cambridge, MA). REF52 cells were transfected
with wild-type or mutant tTG cDNAs or FXIIIa cDNA in pcDNA3.1-zeo
vector (Invitrogen) using Superfect™ (Quiagen) and selected with 100 
 
m
 
g/ml
zeocin™ (Invitrogen). 
 
b
 
1 integrin cDNAs, CHO cell lines expressing 
 
b
 
1
integrin cytoplasmic domain variants, and antibodies against integrin sub-
units were described previously (Belkin et al., 1996, 1997; Retta et al.,
1998).
 
Assays for Cell Adhesion and Spreading on Fn and
Fn Fragments
 
Glass coverslips or 24-well plastic wells were coated with 10 
 
m
 
g/ml Fn,
110-kD cell-binding, or 42-kD gelatin-binding Fn fragment for 1 h at 37
 
8
 
C,
blocked with 10 mg/ml BSA, and then used for cell plating. Since trypsin
rapidly degrades cell surface tTG, we used EDTA for cell detachment
in adhesion and spreading experiments. 
 
35
 
S-labeled WI-38 fibroblasts,
REF52 transfectants, and untreated or 12-
 
O-
 
tetradecanoylphorbol 13-
acetate (TPA)-treated HEL cells were preincubated with 20 
 
m
 
g/ml cyclo-
heximide for 2 h in serum-free medium, detached with EDTA, and plated
on protein-coated wells (1.5 
 
3
 
 10
 
6
 
 cpm/well) for 1 h in serum-free medium
with 10 mg/ml BSA and cycloheximide. In some cases, WI-38 fibroblasts
or HEL cells were preincubated for 30 min on ice with 10 
 
m
 
g/ml anti-tTG
mAbs TG100, CUB7402, or polyclonal antibody, or blocking anti–
 
b
 
1 inte-
grin mAb JB1A (Chemicon). WI-38 cells were also plated on 42-kD Fn
fragment in the presence of 10 
 
m
 
M tTG
 
1-165
 
 or 200 
 
m
 
M GRGDSP or
GRGESP peptides. After 1 h, cells were washed three times with PBS,
lysed in 1% SDS, and bound radioactivity was determined by scintillation
counting. Adhesion on ovalbumin was used as a negative control. The
number of adherent cells in each experiment was determined based on in-
corporation of 
 
35
 
S radioactivity per 10
 
3
 
 cells.
For spreading assays, unlabeled WI-38, REF52 fibroblasts, or HEL
cells were plated for 4 h on protein-coated glass coverslips using the condi-
tions of adhesion experiments. Coverslips were washed with PBS, fixed
with 3% formaldehyde, stained with Coomassie blue, destained, and pho-
tographed. To quantitate the degree of spreading of WI-38 fibroblasts and
REF52 transfectants on Fn and Fn fragments over a time course, the cells
were plated on the substrates for 30–180 min using the above mentioned
conditions. The cells were fixed at certain timepoints, stained with Coo-
massie blue, and the average spreading areas were determined for 90–120
cells not contacting each other using a video monitor to trace the perime-
ters of adherent cells.
 
Analysis of Integrin Association with tTG by 
Coimmunoprecipitation and Affinity Isolation on Fn 
and Fn Fragments
 
Adherent or suspended cells were washed with PBS and lysed in ice-cold
RIPA buffer, containing 1% Triton X-100, 0.5% Na-deoxycholate, 0.1%
SDS, 150 mM NaCl, 50 mM TrisCl, pH 7.5, with 0.5 mM PMSF, 0.5 mM
benzamidine, 10 
 
m
 
g/ml leupeptin, and 10 
 
m
 
g/ml aprotinin. Cell lysates
were precleared by centrifugation (14,000 rpm for 30 min at 4
 
8
 
C). 1 mg of
total cellular protein or 3 
 
3
 
 10
 
8
 
 cpm of protein-incorporated 
 
35
 
S radioac-
tivity was used for each sample in immunoprecipitation or affinity binding
experiments. RIPA cell lysates were used for immunoprecipitation with
antibodies (2–8 
 
m
 
g per sample) against integrins or tTG, followed by pro-
tein G–Sepharose, or used for binding assays with 100 
 
m
 
l of immobilized
Fn and Fn fragments (1 mg protein/ml Sepharose).
Cell surface biotinylation of 2 
 
3
 
 10
 
7
 
 EDTA-detached TPA-differenti-
ated HEL cells was performed in PBS containing 0.1 mg/ml membrane-
impermeable biotinylation agent Sulfo-NHS-Biotin (Pierce) for 20 min,
and the reaction was quenched with 20 mM Tris in PBS. Biotinylated pro-
teins were visualized on the blots with neutravidin-peroxidase (Pierce).
Immunodepletion analysis and reprecipitation were performed as de-
scribed (Berditchevski et al., 1996). Pulse-chase analysis of integrin bio-
synthesis was described earlier (Akiyama and Yamada, 1987). In brief, 5 
 
3
 
10
 
6
 
 TPA-treated HEL cells were pulse-labeled for 1 h with 200 
 
m
 
Ci/ml
 
35
 
S[Translabel] (a mixture of [
 
35
 
S]methionine and [
 
35
 
S]cysteine; ICN Ra-
diochemicals). Then it was replaced with the normal growth medium for
0–18 h. The cells were washed with PBS, lysed in RIPA buffer, and cell ly-
sates were used to immunoprecipitate 
 
b
 
1 integrins. After immunoprecipi-
tation, the resulting immune complexes were split into halves and half of
each sample was boiled in SDS sample buffer. The other half of each sam- 
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ple was boiled in 1% SDS, the eluate was reconstituted with 1% Triton
X-100, 150 mM NaCl, 50 mM TrisCl, pH 7.5, to a final SDS concentration
of 0.1%, and subjected to reprecipitation with polyclonal antibody to tTG.
The resulting 
 
b
 
1 integrin immune complexes and tTG immunoprecipi-
tates were analyzed by SDS-PAGE and autoradiography.
To analyze association of tTG and Fn with 
 
b
 
1 integrins in WI-38 fibro-
blasts, cells were labeled overnight with 50 
 
m
 
Ci/ml [
 
35
 
S]Translabel. 
 
35
 
S-
labeled RIPA lysates were subjected to immunoprecipitation with mAb
CUB7402 against tTG or mAb 9EG7 against human 
 
b
 
1 integrin. An ex-
cess (1 
 
m
 
M) of unlabeled Fn, 110-kD Fn fragment, 42-kD Fn fragment, or
5 
 
m
 
M unlabeled tTG fragment tTG
 
1-165
 
 was added to some immunoprecip-
itation samples during incubations with primary antibodies and protein
G–Sepharose. After immunoprecipitation, the immune complexes were
split into halves and half of each sample was boiled in SDS sample buffer.
The other half was boiled in 1% SDS, the eluate was reconstituted with
1% Triton X-100, 150 mM NaCl, 50 mM TrisCl, pH 7.5, to a final SDS
concentration of 0.1%, and subjected to reprecipitation with polyclonal
antibody to Fn. Immunoprecipitates were washed several times with
RIPA buffer, and analyzed by SDS-PAGE and autoradiography.
For coimmunoprecipitation and affinity isolation experiments with
HEL cells, they were labeled overnight with 50 
 
m
 
Ci/ml [
 
35
 
S]Translabel. To
increase tTG synthesis, HEL cells were plated on Fn and treated with 150
ng/ml TPA for 24–48 h. After the treatment, 85–90% of cells in the popu-
lation became adherent and spread. Both untreated and TPA-treated 
 
35
 
S-
labeled cells were lysed in RIPA buffer, and precleared lysates were used
for immunoprecipitation or affinity binding to Fn and Fn fragments.
To visualize 
 
35
 
S-labeled proteins, SDS-PAGE in 10% acrylamide/
0.25% bis-acrylamide gels was followed by treatment of gels with Auto-
fluor (Amersham Pharmacia Biotech) and fluorography. tTG was de-
tected on blots with 0.4 
 
m
 
g/ml mAb TG100 and FXIIIa with 0.5 
 
m
 
g/ml
polyclonal antibody. For immunoblotting of 
 
b
 
1 and 
 
b
 
3 integrins, antibod-
ies to 
 
b
 
1A cytodomain or 
 
b
 
3 integrin subunit (Chemicon) were used at 0.5
 
m
 
g/ml. Blots were developed with peroxidase-conjugated secondary IgG
(Chemicon) and ECL reagents (Pierce).
 
Cross-Linking Experiments
 
To analyze association of cell surface tTG with integrins, cross-linking ex-
periments were performed as follows. 2 
 
3
 
 10
 
7
 
 TPA-treated HEL cells
were detached with EDTA and live cells were incubated for 20 min at
20
 
8
 
C in PBS containing 0.5 mM membrane-impermeable cross-linker
Dithiobis (sulfosuccinimidylpropionate) (DTSSP; Pierce). The reaction
was stopped by adding 20 mM TrisCl, pH 7.5. The cells were pelleted,
washed twice with PBS, and lysed in ice-cold RIPA buffer with protease
inhibitors. 
 
b
 
1, 
 
b
 
2, and 
 
b
 
3 integrins and tTG were immunoprecipitated
from RIPA lysates of DTSSP-treated cells as described above. Immuno-
precipitation samples were divided into halves and boiled in SDS-PAGE
sample buffer either without or with reducing agents, and analyzed on
10% gels. To avoid an appearance of large IgG bands on the blot with the
nonreduced immunoprecipitates, it was developed with 0.3 
 
m
 
g/ml biotin-
ylated mAb TG100 against tTG, followed by neutravidin-peroxidase.
 
Immunofluorescence
 
Live nonpermeabilized REF52 cells transfected either with vector alone
or with tTG cDNA were double stained with 10 
 
m
 
g/ml anti-tTG mAb
CUB7402 and 20 
 
m
 
g/ml hamster mAb HM 
 
b
 
1-1 to rat 
 
b
 
1 integrin. To lo-
calize tTG and 
 
b
 
1 integrins during spreading of tTG transfectants on
42-kD Fn fragment, the cells were fixed with 3% formaldehyde in PBS 1
or 2 h after plating and then double stained without cell permeabilization.
A combination of rhodamine-conjugated donkey anti–mouse IgG and flu-
orescein-conjugated goat anti–hamster IgG (Chemicon) were used as sec-
ondary antibodies. To visualize focal adhesions and actin stress fibers,
cells were fixed with 3% formaldehyde, permeabilized with 0.5% Triton
X-100 in PBS, and then costained with 10 
 
m
 
g/ml antivinculin mAb 7F9 and
rhodamine-phalloidin (1:500), followed by fluorescein-conjugated donkey
anti–mouse IgG (Chemicon).
 
Flow Cytometry
 
For flow cytometry, live REF52 transfectants were stained for cell surface
tTG with 10 
 
m
 
g/ml polyclonal anti-tTG antibody. Staining for cell surface
FXIIIa was performed with 10 
 
m
 
g/ml polyclonal antibody. After incuba-
tion with secondary fluorescein-labeled IgG, the cells were analyzed in
FACScan™ flow cytometer (Becton Dickinson).
 
Measurements of Transglutaminase Activity
 
Transglutaminase activity in cell lysates (cytosolic fractions) of REF52
transfectants was measured by incorporation of [
 
3
 
H]putrescine into N,N-
dimethylcaseine as described previously (Lorand et al., 1972; Jones et al.,
1997; Verderio et al., 1998). Transglutaminase activity on the surface of
live REF52 transfectants or HEL cells was determined as reported earlier
(Verderio et al., 1998), with some modifications. 2 
 
3
 
 10
 
6
 
 live EDTA-
detached cells in 0.5 ml PBS containing 2 mM Ca
 
11
 
 and 10 mg/ml N,N-
dimethylcaseine, were incubated with 10 
 
m
 
Ci [
 
3
 
H]putrescine for 1 h at
37
 
8
 
C on the rotator. Supernatants were precipitated with ice-cold 10%
TCA, the pellets were washed sequentially with 5% TCA, ice-cold etha-
nol, acetone, then dried and redissolved in 100 
 
m
 
l 1% SDS. Protein-incor-
porated 
 
3
 
H radioactivity was determined by scintillation counting.
 
Adhesion-dependent Focal Adhesion
Kinase Phosphorylation
 
For focal adhesion kinase (FAK) phosphorylation experiments, 2 
 
3 
 
10
 
5
 
REF52 transfectants were either kept in suspension or plated for 3 h in se-
rum-free medium containing 20 
 
m
 
g/ml cycloheximide on dishes precoated
with Fn, Fn fragments, laminin, or anti-tTG antibodies. To perform a time
course analysis of FAK phosphorylation with the transfectants, the cells
were plated on Fn for 45, 90, and 180 min. Immunoprecipitation of FAK
from cell lysates with polyclonal antibody 5158 and immunoblotting for
phosphotyrosine were describred earlier (Belkin et al., 1996).
 
Results
 
Cell Surface tTG Is an Adhesion Receptor for the
42-kD Fragment of Fn
 
tTG binds in vitro with high affinity to the 42-kD gelatin-
binding domain of Fn (Turner and Lorand, 1989; Radek
et al., 1993). Since this enzyme is present on the surface of
some cells (Upchurch et al., 1991; Aeschlimann et al.,
1995; Verderio et al., 1998), its ability to bind Fn might
contribute to cell adhesion. Therefore, we examined the
effects of anti-tTG antibodies on adhesion and spreading
of WI-38 fibroblasts that express tTG on their surface
(Upchurch et al., 1991). These cells adhered and spread
on surfaces coated with Fn and its 110-kD fragment as
well as its 42-kD fragment, although spreading was some-
what less on the latter (Fig. 1 B, upper panels). Treatment
with the polyclonal anti-tTG antibody moderately de-
creased spreading of WI-38 fibroblasts on Fn, had no ef-
fect on 110-kD Fn fragment, but completely abolished
spreading of these cells on the 42-kD Fn fragment (Fig. 1
B, lower panels). A recombinant NH
 
2
 
-terminal tTG do-
main, tTG
 
1-165
 
, which binds Fn in vitro (Jeong et al., 1995),
strongly decreased spreading of WI-38 fibroblasts on the
42-kD fragment, whereas GRGDSP peptide and function-
blocking anti–
 
b
 
1 integrin mAb JB1A had no effect (Fig. 1
C). In quantitative adhesion assays, tTG
 
1-165
 
 and two anti-
bodies against tTG markedly inhibited adhesion of WI-38
fibroblasts to the 42-kD fragment, while having little or no
effect on adhesion to Fn or its 110-kD fragment (Fig. 1 D).
In contrast, the function-blocking anti–
 
b
 
1 integrin mAb
JB1A, which strongly decreased adhesion of WI-38 fibro-
blasts to Fn and even more to the 110-kD fragment, had
very little effect on adhesion to the 42-kD fragment (Fig. 1
D). A time course analysis demonstrated a potent inhibi-
tion of spreading of WI-38 fibroblasts on Fn and its 42-kD
fragment by polyclonal anti-tTG antibody (Fig. 1 E). To-
gether, these results show that surface tTG mediates adhe-
sion and spreading of fibroblasts on the 42-kD gelatin- 
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binding domain of Fn, which does not contain integrin-
binding motifs.
It was reported earlier that HEL cells that normally
grow in suspension adhere to Fn after treatment with TPA
(Jarvinen et al., 1987; Ylanne et al., 1990). Using flow cy-
tometry with live HEL cells, we found that TPA treatment
increased the level of surface tTG (Fig. 2 A). In parallel,
transglutaminase activity on the surface of live TPA-
treated HEL cells rose 
 
z
 
10-fold compared with untreated
cells (Fig. 2 B). Quantitative adhesion experiments dem-
onstrated that TPA treatment increased adhesion to Fn,
and even more so to the 42-kD Fn fragment, without af-
fecting adhesion to the 110-kD fragment of Fn (Fig. 2 C).
Importantly, the antibody against tTG negated the effects
of TPA on cell adhesion to Fn and to the 42-kD Fn frag-
ment. Similarly, spreading of HEL cells on Fn and its 42-
kD fragment was enhanced by TPA, and this effect was
abolished by anti-tTG antibody (Fig. 2 D). These observa-
tions indicate that the induction of cell surface tTG can
play a major role in stimulation of cell adhesion and
Figure 1. Surface tTG medi-
ates adhesion and spreading
of WI-38 fibroblasts on 42-
kD Fn fragment. (A) A
scheme of modular structure
of Fn and its 42-kD and 110-
kD proteolytic fragments. (B
and C) Spreading assays with
WI-38 fibroblasts. (B) Cells
were plated for 4 h on Fn,
110-kD, or 42-kD Fn frag-
ments either untreated or in
the presence of 10 mg/ml
polyclonal anti-tTG anti-
body. (C) Cells were plated
for 4 h on 42-kD Fn fragment
in the presence of 10 mM
recombinant NH2-terminal
tTG domain tTG1-165, 200 mM
GRGDSP or GRGESP pep-
tides, or 10 mg/ml function-
blocking mAb JB1A against
human b1 integrins. Bar, 20
mM. (D) Quantitative ad-
hesion assays with WI-38 fi-
broblasts plated for 1 h on
Fn (open bars), 110-kD
(crossed bars), and 42-kD
(filled bars) fragments with-
out treatment or in the pres-
ence of 10 mM tTG1-165, 10
mg/ml mAb CUB7402, 10 mg/ml
polyclonal anti-tTG antibody,
or 10 mg/ml blocking anti-b1
integrin mAb JB1A. Shown
are the means of quadrupli-
cate measurements. (E) Quan-
titative spreading assays with
WI-38 fibroblasts plated on
Fn or 42-kD Fn fragment for
30–180 min either without
treatment or in the presence
of 10 mg/ml polyclonal anti-
tTG antibody. Shown are the
average areas on substrate
for 120 cells. (B–E) Adhesion
and spreading assays were
performed with cells in se-
rum-free medium in the pres-
ence of cycloheximide.Akimov et al. The Role of Tissue Transglutaminase in Cell Adhesion 829
spreading due to its interaction with the 42-kD gelatin-
binding domain of Fn.
Stimulation of Cell Adhesion and Spreading by tTG Is 
Not Shared by its Homologue FXIIIa and Does Not 
Require tTG Cross-Linking Activity
To explore further the role of tTG in cell adhesion, rat
REF52 fibroblasts were transfected with human tTG or its
enzymatically inactive mutant C277®S. Flow cytometry of
live REF52 transfectants was performed with a polyclonal
anti-tTG antibody that recognizes both rat and human
tTG. The cells expressing human tTG or tTG[C277®S] had
increased amounts of tTG on the surface compared with
vector controls, showing that both proteins were exported
to the cell surface (Fig. 3 A). However, transfection of
REF52 cells with human FXIIIa cDNA did not result in
surface expression or secretion of this protein, indicating
that mechanisms of externalization of these two trans-
glutaminases are different (Fig. 3 B). Expression of tTG or
FXIIIa, but not of the catalytic mutant tTG[C277®S], in-
creased transglutaminase activity in the cytosolic fractions
of the transfectants compared with vector-expressing cells
(Fig. 3 C). Measurements of transglutaminase activity on
the surface of live transfectants revealed a sharp increase
after transfection with tTG, a reduction after transfec-
tion with tTG[C277®S], and no change in cells expressing
FXIIIa (Fig. 3 D). In agreement with previous reports
(Gentile et al., 1992; Verderio et al., 1998), overexpression
of tTG strongly promoted cell spreading (Fig. 3 E). Interest-
ingly, REF52 cells expressing tTG[C277®S] also appeared
significantly more spread in regular culture than vector-
transfected controls or FXIIIa transfectants (Fig. 3 E).
When plated on Fn in the presence of cycloheximide,
tTG transfectants displayed increased spreading compared
with control cells, as did the tTG[C277®S] mutant transfec-
tants (Fig. 4 A). Spreading on 110-kD Fn fragment was
unaffected by transfection with tTG or tTG[C277®S] (Fig.
4 A). Most notably, cells expressing exogenous tTG or
tTG[C277®S] spread much better than vector-transfected
cells on the 42-kD Fn fragment (Fig. 4 A). Again, the ob-
served stimulation of cell spreading appeared to be spe-
cific for cell surface tTG, since no changes were seen for
FXIIIa transfectants (Fig. 4 A).
Figure 2. TPA-induced ad-
hesion and spreading of HEL
cells on 42-kD Fn fragment is
mediated by surface tTG.
(A) Expression levels of tTG
on the surface of live un-
treated and TPA-treated
cells were determined by im-
munostaining with 10 mg/ml
polyclonal anti-tTG anti-
body and flow cytometry. (B)
Transglutaminase activity on
the surface of live untreated
and TPA-treated cells was
quantified by measuring cell-
mediated incorporation of
[3H]putrescine into N,N-dimeth-
ylcaseine. Bars show the
means of triplicate measure-
ments. (C) Quantitative ad-
hesion assays with untreated
and TPA-treated cells plated
for 1 h on Fn (open bars),
110-kD (crossed bars), and
42-kD (filled bars) fragments
either without or in the pres-
ence of 10 mg/ml polyclonal
anti-tTG antibody. (D)
Spreading assays with un-
treated and TPA-treated
cells. Cells were plated for
4 h on Fn, 110-kD, or 42-kD
Fn fragments without any
treatment or after TPA treat-
ment either in the absence or
with 10 mg/ml polyclonal anti-
tTG antibody. Bar, 20 mM. (C
and D) For adhesion and
spreading assays HEL cells
were plated in serum-free
medium in the presence of
cycloheximide.The Journal of Cell Biology, Volume 148, 2000 830
Quantitative adhesion assays with REF52 cells overex-
pressing tTG or its enzymatically inactive mutant C277®S
showed that their adhesion on Fn or its 110-kD fragment
was not significantly altered, but adhesion on the 42-kD
Fn fragment was strongly promoted (Fig. 4 B). Expression
of exogenous tTG or tTG[C277®S] also drastically en-
hanced spreading over time in cells plated on Fn (Fig. 4 C)
or the 42-kD Fn fragment (Fig. 4 D). No significant changes
were detected in quantitative adhesion and spreading as-
says for FXIIIa transfectants (Fig. 4, B–D). Collectively,
these results show that the enzymatic activity of tTG is
not required for the enhancement of cell adhesion and
spreading.
tTG Interacts Directly with Multiple b1 and
b3 Integrins
Cell spreading on ECM is an active process that requires
outside-in signaling. Surprisingly, surface tTG is capable
of promoting cell spreading on Fn and its 42-kD fragment,
even though it lacks a transmembrane domain (Gentile et al.,
1991). Therefore, we hypothesized that tTG might interact
and collaborate with some transmembrane adhesion re-
ceptors, possibly integrins. Immunoprecipitation of b1 in-
tegrins from REF52 transfectants, followed by immuno-
blotting for tTG, showed that endogenous rat tTG as well
as transfected human tTG and tTG[C277®S], both of
which migrate slower on gels, all coprecipitated with en-
dogenous b1 integrins (Fig. 4 E). No tTG could be de-
tected in the immunoprecipitates with antibody against
FGF receptor FGFR-1, proving specificity of immunopre-
cipitation (Fig. 4 E). Although a large amount of FXIIIa
was expressed in REF52 transfectants, no association of
FXIIIa with b1 integrins was detected by coimmunopre-
cipitation in this cell line (Fig. 4 F). These data suggested
that tTG might specifically associate with integrins.
Immunoprecipitation in RIPA buffer, which disrupts in-
tegrin–ligand interactions (data not shown), was used to
isolate integrin–tTG complexes from cell lysates. We initi-
ated the analysis with HEL cells because they do not syn-
thesize any detectable Fn (Jarvinen et al., 1987). A pre-
dominant 80-kD protein that comigrated with tTG and
coprecipitated with b1 integrins from lysates of 35S-labeled
TPA-treated HEL cells was immunodepleted with poly-
clonal antibody against tTG, strongly suggesting that it is
tTG (Fig. 5 A, arrow). Additionally, after preadsoption of
tTG, the intensity of the b1 integrin band slightly de-
creased, whereas a detectable amount of b1 integrin ap-
peared in tTG immunoprecipitates (Fig. 5 A). The identity
of the 80-kD protein was further proved by reprecipitation
experiments (Berditchevski et al., 1996). b1 integrins were
first immunoprecipitated from 35S-labeled HEL cells using
Figure 3. Expression of exogenous tTG or its enzymatically inactive mutant tTG[C277®S], but not of FXIIIa promotes cell spreading.
(A–E) REF52 cells were transfected with vector (vect.), wild-type tTG (tTG), tTG noncatalytic mutant C277®S (tTG[C277-S]), or FXIIIa
(FXIIIa). (A) Expression levels of tTG on the surface of live transfectants were determined by immunostaining with 10 mg/ml poly-
clonal anti-tTG antibody and flow cytometry. (B) Expression levels of FXIIIa on the surface of live transfectants were determined by
immunostaining with 10 mg/ml polyclonal antibody against FXIIIa and flow cytometry. (C) Transglutaminase activity in the cytosolic
fractions of the transfectants was quantified by incorporation of [3H]putrescine into N,N-dimethylcaseine by transamidating enzymes
present in cell lysates (Lorand et al., 1972). Shown are the results of triplicate determinations. (D) Transglutaminase activity on the sur-
face of live transfectants was quantified by measuring cell-mediated incorporation of [3H]putrescine into N,N-dimethylcaseine. Bars
represent the means of triplicate measurements. (E) Cells expressing vector, tTG, tTG[C277®S], or FXIIIa were photographed in regu-
lar culture. Bar, 20 mM.Akimov et al. The Role of Tissue Transglutaminase in Cell Adhesion 831
mAb 9EG7 (Fig. 5 B). The resulting immune complexes
were then eluted with either 0.4% SDS at 258C or 1% SDS
with boiling and reprecipitated with antibody against the
cytoplasmic domain of b1A integrin (Fig. 5 B, lane 1) or
three anti-tTG antibodies (Fig. 5 B, lanes 2–4). The 80-kD
protein appeared in all cases, proving its identity as tTG
(Fig. 5 B, arrow). Notably, b1 integrins coprecipitated with
tTG even after treatment with 0.4% SDS, showing ex-
tremely stable association between these proteins (Fig. 5
B, left panel). However, after boiling in 1% SDS, integrins
no longer coprecipitated with tTG (Fig. 5 B, right panel),
demonstrating that their association is noncovalent. The
absence of other 35S-labeled proteins in b1 integrin or tTG
immunoprecipitates after reprecipitation proves that this
association is highly specific and is not mediated by a third
protein.
Pulse-chase analysis and immunoprecipitation of b1 in-
tegrins from TPA-induced HEL cells showed that immedi-
ately after 1 h labeling, an 80-kD protein was complexed
with b1 integrins (Fig. 5 C, upper panel, arrow). At this
timepoint, de novo synthesized b1 integrins exist as under-
glycosylated precursors which have yet to be exported to
the cell surface (Akiyama and Yamada, 1987). Reprecipi-
tation of tTG from b1 integrin immune complexes demon-
strated that the 80-kD protein represents tTG (Fig. 5 C,
lower panel). Early association of tTG with b1 integrins
indicated that this interaction occurs during integrin bio-
synthesis and maturation inside the cell.
Figure 4. tTG-dependent
stimulation of cell adhesion
and spreading on Fn and its
42-kD fragment does not re-
quire the cross-linking activ-
ity. (A) Spreading assays
with REF52 transfectants.
Cells expressing vector, tTG,
tTG[C277®S], or FXIIIa
were plated for 4 h on Fn,
110-kD, or 42-kD Fn frag-
ments. Bar, 20 mM. (B)
Quantitative adhesion as-
says with REF52 transfec-
tants plated for 1 h on Fn
(open bars), 110-kD (crossed
bars), and 42-kD (filled
bars) fragments. Shown are
the means of quadruplicate
measurements. (C and D)
Quantitative spreading as-
says with REF52 transfec-
tants. Cells expressing vec-
tor, tTG, tTG[C277®S], or
FXIIIa were plated for 30–
180 min on Fn (C) or the 42-
kD Fn fragment (D). Shown
are the average areas on the
substrates for 90 cells. (A–D)
Cells were plated for adhe-
sion and spreading assays in
serum-free cycloheximide-
containing medium. (E)
Analysis of tTG association
with b1 integrins. FGF re-
ceptor,  b1 integrins, and tTG
were immunoprecipitated
with polyclonal antibody
Flg(H-76) or HMb1-1 and
CUB7402 mAbs, respec-
tively, from REF52 cells ex-
pressing vector, tTG or
tTG[C277®S]. The resulting
immunoprecipitates were
blotted for tTG. Large arrow
marks the transfected human
tTG and small arrow indi-
cates the endogenous rat
tTG. (F) FXIIIa is not associated with b1 integrins. FGF receptor, b1 integrins, and FXIIIa were immunoprecipitated from FXIIIa-
expressing REF52 cells and the resulting immunoprecipitates were probed for FXIIIa with a polyclonal antibody.The Journal of Cell Biology, Volume 148, 2000 832
Analysis of complex formation between ab integrin het-
erodimers and tTG in PAC-1 rat smooth muscle cells
by coimmunoprecipitation and immunoblotting for tTG
showed that tTG associates with a1b1, a3b1, a5b1, as well
as avb3 integrins (Fig. 5 D). We also tested CHO cells
transfected with human integrins b1A, b1D, and b1Dcyto
(b1 subunit with a deleted cytodomain) (Belkin et al.,
1996, 1997; Retta et al., 1998), and found all of these inte-
grins to associate with tTG, indicating that b subunit cyto-
plasmic domains are not required for integrin complex for-
mation with tTG (Fig. 5 E).
Detection of tTG Complexes with b1 and b3 Integrins 
on the Cell Surface
To test association of tTG with other integrins on the cell
surface, we biotinylated cell surface proteins on live TPA-
differentiated HEL cells that express high levels of b1, b2,
and  b3 integrins. Immunoprecipitation with antiintegrin
antibodies followed by blotting with avidin-peroxidase re-
vealed an 80-kD protein that comigrated with tTG and
was associated with b1 and b3, but not with b2 integrins
(Fig. 6 A, upper panel, arrow). Furthermore, proteins that
comigrated with b1 and b3, but not with b2 integrins,
could be detected in tTG immunoprecipitates (Fig. 6 A,
upper panel). The identity of the 80-kD protein as tTG
and its lack of association with b2 integrins was confirmed
by blotting the corresponding immunoprecipitates for tTG
(Fig. 6 A, lower panel).
We also tested whether tTG can be chemically cross-
linked to cell surface integrins (Fig. 6 B). After treatment
of live TPA-induced HEL cells with membrane-imperme-
able reducible cross-linker DTSSP, we immunoprecipi-
tated  b1, b2, and b3 integrins and tTG from RIPA lysates
Figure 5. tTG associates
with multiple b1 and b3 inte-
grins in different cell types.
(A) Immunodepletion. An
80-kD protein associated
with  b1 integrins is immuno-
depleted with anti-tTG anti-
body. b1 integrins and tTG
were immunoprecipitated
from RIPA lysates of TPA-
treated  35S-labeled HEL cells
with mAb 9EG7 or poly-
clonal anti-tTG antibody,
respectively. Note a co-
migration of 80-kD protein
coprecipitating with b1 inte-
grins, with tTG (arrow).
Preadsorbtion of 35S-labeled
RIPA lysates with polyclonal
anti-tTG antibody followed
by immunoprecipitation of
b1 integrins with mAb 9EG7
caused a disappearance of
80-kD protein from the b1
integrin immunoprecipitates.
Arrows in A–E point to tTG
bands. Brackets in A and B
mark a5b1 integrin. (A–C)
Molecular weight markers
are shown to the right of the
gels. (B) Reprecipitation. An
80-kD protein associated
with  b1 integrins is reprecipi-
tated by three antibodies against tTG. b1 integrins were immunoprecipitated from RIPA lysates of TPA-treated 35S-labeled HEL cells
with 9EG7 mAb. The 35S-labeled b1 integrin immune complexes were treated with 0.4% SDS (left panel) or boiled in 1% SDS (right
panel). 35S-labeled eluates from the b1 integrin immune complexes were divided into four equal aliquots and subjected to reprecipita-
tion in RIPA buffer with antibody against b1A integrin cytodomain (lane 1), anti-tTG polyclonal antibody (lane 2), mAb CUB7402
(lane 3), or mAb TG100 (lane 4) against tTG. (C) tTG interacts with b1 integrins inside the cell during biosynthesis. TPA-treated HEL
cells were labeled with [35S]Translabel for 1 h, then chased with regular medium for 0, 2, 6, or 18 h. b1 integrins were immunoprecipi-
tated from 35S-labeled RIPA lysates with 9EG7 mAb. The resulting immunoprecipitates were divided into halves. Half of each sample
was run on the gel (upper panel), whereas another half was boiled in 1% SDS and tTG was reprecipitated from these samples using
anti-tTG polyclonal antibody (lower panel). Large and small arrowheads point to mature b1 integrin and its underglycosylated precur-
sor, respectively. (D) Association of tTG with multiple integrins. Immunoprecipitates from PAC-1 smooth muscle cells with antibodies
against a1, a3, a5, av, b1, and b3 integrins, FGF receptor, tTG, or without primary antibody (cont.) were blotted for tTG. (E) b1 inte-
grin cytodomain is not required for binding tTG. Transfected human and endogenous hamster b1 integrins were immunoprecipitated
with mAbs TS2/16 and 7E2, respectively, from CHO cells expressing exogenous b1A, b1D, or b1 integrin with deleted cytodomain. No
primary antibody was used in control immunoprecipitations (cont.). The immunoprecipitates were blotted for tTG.Akimov et al. The Role of Tissue Transglutaminase in Cell Adhesion 833
and subjected the resulting immune complexes to SDS-
PAGE and immunoblotting for tTG. Under nonreducing
conditions, tTG appeared exclusively as a high molecu-
lar weight complex immunoprecipitated with antibodies
against  b1 and b3 integrins, but not with antibody to b2 in-
tegrin (Fig. 6 B, upper panel). The sample immunoprecipi-
tated with antibody against tTG revealed two bands corre-
sponding in mobility to those obtained with anti-b1 and
anti-b3 antibodies. Under reducing conditions, all of the
tTG migrated as an 80-kD protein (Fig. 6 B, lower panel).
The apparent molecular weight of the complexes with b1
(Mr z210,000) and b3 (Mr z195,000) integrins, strongly
suggests a stoichiometry of 1:1 of integrin–tTG complexes.
The absence of any other tTG-containing bands in the
nonreduced samples indicates that all the cell surface tTG
is associated with b1 or b3 integrins.
tTG Mediates the Formation of Ternary Complexes of 
b1 and b3 Integrins with Fn via Its Interaction with the 
42-kD Fn Fragment
The foregoing data demonstrate that tTG functions as a
cell adhesion receptor for the gelatin-binding region of Fn
and interacts with b1 and b3 integrins. We next examined
biochemically whether tTG by itself can mediate associa-
tion of integrins with this part of Fn, which lacks integrin-
binding motifs. First, a protein corresponding to Fn was
observed in both tTG and b1 integrin immunoprecipitates
from  35S-labeled WI-38 human fibroblasts (Fig. 7 A, ar-
rowhead). Addition of unlabeled Fn or its 42-kD fragment
to the 35S-labeled RIPA lysates effectively displaced
35S-labeled Fn from the b1 integrin immunoprecipitates,
Figure 6. tTG is associated with b1 and b3, but not with b2 inte-
grins on the cell surface. (A) Interaction of tTG with b1 and b3
integrins on the cell surface. (Upper panel) TPA-differentiated
HEL cells were biotinylated in suspension and b1, b2, and b3 in-
tegrins and tTG were immunoprecipitated from RIPA lysates of
surface-biotinylated cells. Anti–mouse IgG was used in control
immunoprecipitations (cont.). Biotinylated proteins in the immu-
noprecipitates were visualized on blots by neutravidin-peroxi-
dase. (Lower panel) The same immunoprecipitates as in the top
panel were blotted for tTG. Note association of tTG with b1 and
b3 but not with b2 integrins. b1, b2, and b3 integrin bands are
marked by arrowheads. Asterisks mark IgG heavy chains. Molec-
ular weight markers are shown to the right of the blot. (B) tTG
can be cross-linked to b1 and b3 integrins on the cell surface.
TPA-differentiated HEL cells were treated for 20 min with 0.5
mM membrane-impermeable reducible cross-linker DTSSP in
suspension and b1, b2, and b3 integrins and tTG were immuno-
precipitated from RIPA lysates. After immunoprecipitation sam-
ples were run on 8% gels under nonreducing (upper panel) or re-
ducing (lower panel) conditions. To avoid the appearance of IgG
bands, the blots were probed for tTG using biotinylated anti-tTG
mAb TG100 followed by neutravidin-peroxidase. Arrow in A
and B points to tTG bands. Molecular weight markers (nonre-
duced: myosin heavy chain, 200 kD; IgG, 160 kD; and BSA, 68 kD)
are shown to the right of the blots.
Figure 7. Interaction of tTG with b1 integrins allows formation
of ternary complexes with Fn. (A) tTG (left lane) or b1 integrins
(all other lanes) were immunoprecipitated from RIPA lysates of
35S-labeled WI-38 fibroblasts either in the presence of 1 mM unla-
beled Fn, its 42-kD fragment, its 110-kD fragment or without any
of these proteins added. (B) tTG (left two lanes) or b1 integrins
(right two lanes) were immunoprecipitated from RIPA lysates of
35S-labeled WI-38 fibroblasts either in the absence or with 5 mM
unlabeled NH2-terminal tTG fragment tTG1-165. After immuno-
precipitation half of each sample shown in A and B was boiled in
1% SDS, reconstituted with 10 volumes of 1% Triton X-100 in
TBS and subjected to reprecipitation with polyclonal antibody
against Fn (C and D). Note a disappearance of 35S-labeled Fn
bands in the samples treated with excess unlabeled Fn, 42-kD Fn
fragment, or tTG1-165, but not with excess unlabeled 110-kD
Fn fragment. Arrowheads indicate Fn bands. Brackets mark
a5b1 integrin. Arrows point to tTG bands. Molecular weight
markers are shown to the right of the gels.The Journal of Cell Biology, Volume 148, 2000 834
whereas unlabeled 110-kD fragment was unable to do so.
None of these treatments decreased the amounts of tTG
associated with b1 integrins (Fig. 7 A, arrow). In parallel
experiments, an NH2-terminal fragment tTG1-165 strongly
inhibited association of Fn with tTG and completely dis-
placed 35S-labeled Fn from both the tTG and b1 integrin
immune complexes (Fig. 7 B, arrowhead). The presence of
Fn in the immunoprecipitates was confirmed by using half
of each sample for reprecipitation with anti-Fn antibody
after boiling the immune complexes in 1% SDS (Fig. 7, C
and D). The use of GRGDSP peptide in coimmunoprecip-
itation assays did not cause any decrease in the amounts of
35S-labeled Fn (data not shown). These data indicate that
in the RIPA lysates Fn interacts indirectly with b1 inte-
grins due to association of its 42-kD fragment with inte-
grin-bound tTG.
An even more convincing proof of this concept came
from experiments with HEL cells, which synthesize essen-
tially no endogenous Fn even when treated with TPA, and
express large amounts of a5b1 and aIIbb3 integrins, which
serve as Fn receptors (Jarvinen et al., 1987; data not
shown). We found that stimulation of these cells with TPA
sharply increased the overall expression of tTG while hav-
ing no effect on the levels of a5b1 and aIIbb3 (see below).
This provided a convenient inducible model with which to
test the ability of tTG to mediate the interaction of inte-
grins with immobilized Fn and its fragments. Affinity chro-
matography of 35S-labeled RIPA lysates of both untreated
and TPA-treated cells (Fig. 8, A and B) showed that tTG
was the predominant protein in the eluates from immobi-
lized Fn and its 42-kD fragment, but did not bind the 110-
kD Fn fragment (Fig. 8, A and B, lanes 2–4). The identity
of tTG was confirmed by immunoprecipitation (Fig. 8, A
and B, lanes 5) and by blotting the unlabeled eluates and
immunoprecipitates for tTG (Fig. 8, G and H). Consistent
with the drastic enhancement of tTG synthesis in HEL
cells by TPA, this treatment also greatly elevated the
amounts of a5b1 and aIIbb3 integrins coprecipitating with
tTG and vice versa (Fig. 8, A–F, lanes 5; Fig. 8, G and H,
lanes 6 and 7). Notably, a5b1 and aIIbb3 integrins bound
to immobilized Fn and its 42-kD fragment, but not to the
110-kD fragment, indicating that binding of these integrins
to Fn and its 42-kD fragment in RIPA buffer is indirect
and mediated by tTG (Fig. 8, A–F, lanes 2–4). As a conse-
Figure 8. tTG mediates asso-
ciation of a5b1 and aIIbb3
integrins with Fn via its 42-
kD fragment. 35S-labeled un-
treated (A) and TPA-treated
(B) HEL cells were extracted
with RIPA buffer (lanes 1).
Cell extracts were incubated
with Sepharose-immobilized
Fn (lanes 2), 110-kD (lanes
3), or 42-kD (lanes 4) Fn
fragments, or immunoprecip-
itated with polyclonal anti-
tTG antibody (lanes 5), anti–
b1 integrin mAb 9EG7
(lanes 6), anti–b3 integrin
mAb 25E11 (lanes 7) or con-
trol Sepharose beads (lanes
8). 35S-labeled eluates from
immobilized Fn and Fn frag-
ments, and immunopre-
cipitates were analyzed by
SDS-PAGE and autoradiog-
raphy. Unlabeled RIPA ex-
tracts of untreated (C, E, and
G) or TPA-treated (D, F,
and H) HEL cells, analogous
to those in A and B, respec-
tively, were incubated with
immobilized Fn and Fn frag-
ments or immunoprecipi-
tated with antibodies against
tTG,  b1, and b3 integrins.
Eluates from immobilized Fn
and Fn fragments and im-
munoprecipitates were ana-
lyzed by SDS-PAGE and
immunoblotting with poly-
clonal antibody to b1A integrin cytodomain (C and D), polyclonal antibody to b3 integrin (E and F), or anti-tTG mAb tTG100 (G and
H). (A and B) Protein bands corresponding to a5, aIIb, b1, and b3 integrins and tTG are marked to the right of each gel. Molecular
weight markers are shown to the left of the gels.Akimov et al. The Role of Tissue Transglutaminase in Cell Adhesion 835
quence of larger amounts of integrin–tTG complexes,
more  a5b1 and aIIbb3 integrins were isolated on Fn and
the 42-kD fragment, from the TPA-treated than from the
untreated cells (Fig. 8, A–F, lanes 2 and 4). Taken to-
gether, these data establish that tTG serves as a bridge to
link a5b1 and aIIbb3 integrins with the gelatin-binding
domain of Fn.
tTG Amplifies Integrin Signaling, Colocalizes with b1 
Integrins on the Cell Surface, and Causes Enlargement 
of Focal Adhesions
Since tTG mediates binding of integrins to Fn, we next an-
alyzed whether tTG functionally collaborates with inte-
grins in adhesion-dependent signal transduction. Analysis
of integrin-mediated tyrosine phosphorylation of FAK
was performed with REF52 cells overexpressing tTG (Fig.
9, A and B). Tyrosine phosphorylation of FAK was very
low in cells in suspension regardless of the levels of tTG
expression (Fig. 9 A). A gradual time-dependent increase
in FAK phosphorylation was observed in both types of
transfectants during adhesion and spreading on Fn, but the
phosphotyrosine content of FAK was consistently higher
in the tTG-transfected cells (Fig. 9 A). We also compared
the extent of FAK phosphorylation in the transfectants
plated on different substrata for 3 h (Fig. 9 B). Unlike in
the case of Fn, no difference was seen for the two cell lines
adhering to 110-kD Fn fragment, despite the substantial
levels of FAK phosphorylation in the transfectants. How-
ever, adhesion on 42-kD Fn fragment or anti-tTG anti-
Figure 9. tTG amplifies inte-
grin-mediated tyrosine phos-
phorylation of FAK and
colocalizes with b1 integrins
at focal adhesions. (A and
B) tTG potentiates FAK
phosphorylation. (A) Time
course of FAK phosphoryla-
tion in REF52 cells express-
ing vector (vect.) or wild-
type tTG (tTG), plated on
Fn. Cells were either kept in
suspension (susp.) or plated
on Fn for 45, 90, or 180 min.
(B) REF52 cells expressing
vector (vect.) or wild-type
tTG (tTG), were plated for
3 h on dishes coated with Fn,
110-kD, or 42-kD Fn frag-
ments, polyclonal anti-tTG
antibody or laminin (Ln). (A
and B) The transfectants
were plated on ECM pro-
teins or anti-tTG antibody in
serum-free medium in the
presence of cycloheximide.
The cells were lysed and
FAK was immunoprecipi-
tated from cell lysates fol-
lowed by SDS-PAGE and
immunoblotting of the im-
mune complexes for phos-
photyrosine with PY20 mAb
(Belkin et al., 1996). (C–E)
tTG colocalizes with b1 in-
tegrins on the cell surface
of REF52 fibroblasts and
causes enlargement of focal
adhesions. (C) Live, nonper-
meabilized cells transfected
with vector (vect.) or tTG
(tTG) were double stained
for cell surface tTG with
mAb CUB7402 and b1 integrins with hamster mAb HMb1-1. Note codistribution of these proteins at focal adhesions and much larger
size of these structures in tTG transfectants. (D) Formaldehyde-fixed, permeabilized cells transfected with vector or tTG, were double
stained for vinculin and actin with mAb 7F9 and rhodamine-phalloidin. Note the increased size of focal adhesions and altered organiza-
tion of actin bundles in the tTG transfectants. (E) Cells overexpressing tTG were plated for 1 or 2 h on 42-kD Fn fragment, fixed, and
then double stained for surface tTG with mAb CUB7402 and b1 integrins with hamster mAb HMb1-1. Arrows indicate focal adhesion
sites. Bar, 20 mM.The Journal of Cell Biology, Volume 148, 2000 836
body caused a much greater increase in FAK phosphoryla-
tion in cells overexpressing tTG compared with vector-
transfected controls. In contrast, the levels of FAK phos-
phorylation were similar in these cell lines after adhesion
on laminin, an ECM protein that does not bind tTG (Aesch-
limann and Paulsson, 1991). Enzymatically inactive mu-
tant tTG[C277®S] had similar effects on integrin signaling
(data not shown). These results demonstrate that associa-
tion of integrin-bound tTG with the 42-kD Fn fragment is
sufficient to trigger tyrosine phosphorylation of FAK even
in the absence of direct integrin–ligand interaction. tTG
also potentiates integrin-mediated FAK phosphorylation
in cells adhering on Fn, showing cooperativity with inte-
grins in outside-in signal transduction.
Since tTG is physically and functionally associated with
integrins, we compared their localization on the cell sur-
face. Immunostaining of live nonpermeabilized REF52
cells on Fn revealed codistribution of tTG and b1 integrins
at focal adhesions (Fig. 9 C, left panels). Overexpression
of tTG showed its accumulation on the surface of REF52
cells in distinct clusters that colocalized with b1 integrins
and appeared much larger in size than focal adhesions in
vector-transfected cells (Fig. 9 C, arrows). Double staining
for vinculin and actin showed an enlargement of focal ad-
hesions in cells overexpressing tTG (Fig. 9 D, arrows).
Also, the overall organization of the actin cytoskeleton in
these cells was altered with a number of thick parallel bun-
dles of actin filaments arranged peripherally (Fig. 9 D).
Notably, b1 integrins were colocalized with tTG in REF52
transfectants spreading on the 42-kD Fn fragment, sug-
gesting that aggregation of surface tTG leads to integrin
clustering (Fig. 9 E, arrows).
Discussion
In this study we describe a novel function of cell surface
tTG as an integrin-associated adhesion coreceptor for Fn.
tTG exerts this function by associating with several b1
and b3 integrins while simultaneously binding to Fn via
its NH2-terminal domain. The latter interaction involves
a previously unrecognized adhesive site on Fn that is lo-
cated within the 42-kD gelatin-binding domain (modules
I6II1,2I7-9) and is distinct from its classical RGD-containing
and all other known cell-binding motifs. Experiments pre-
sented in this study prove that cells can adhere, spread,
and form focal adhesions on the isolated 42-kD Fn frag-
ment, and that surface tTG is critical for these processes.
tTG also promotes adhesion and enhances spreading, fo-
cal adhesion formation, and adhesion-triggered signaling
of cells adhering to whole Fn.
A recent work by Hocking et al. (1998) reported that
the 70-kD NH2-terminal Fn fragment, which includes the
42-kD gelatin-binding domain, binds directly to a5b1 inte-
grin and elicits integrin-mediated signals. These effects were
attributed to the 29-kD Fn fragment (modules I1-5), and
not to the adjacent 42-kD domain. In addition, another re-
cent study showed that numerous isolated type III mod-
ules of Fn can support cell adhesion by interacting with
integrins, therefore greatly expanding the number of po-
tential integrin-binding adhesive sites in Fn (Chi-Rosso et
al., 1997). In our work, we demonstrate that another part
of the Fn molecule, its 42-kD gelatin-binding domain that
lacks integrin-binding motifs and does not interact with
purified integrins in vitro, contributes to cell adhesion. In
contrast to other reports on integrin-Fn association, we
show that integrins can interact with Fn indirectly, and cell
surface tTG mediates the interaction of integrins with the
gelatin-binding domain of Fn.
The adhesive function of tTG strictly depends on its in-
teraction with integrins. We estimate that in different cell
types, 5–40% of b1 integrins are complexed with tTG. In
contrast, only 0.5–10% of the total tTG cellular pool is as-
sociated with integrins; the great majority of tTG resides
in the cytoplasm, making it often difficult to detect inte-
grins in tTG immunoprecipitates from whole cell lysates.
On the other hand, the chemical cross-linking experiments
indicate that all the tTG on the cell surface is present as 1:1
complexes with integrins. The interaction of tTG with in-
tegrins occurs primarily via the extracellular domains of
integrin b subunits. Among several integrins containing
homologous b1, b2, and b3 subunits, only members of the
b1 and b3 subfamilies interact with tTG, whereas b2 inte-
grins do not. This emphasizes the specificity of this interac-
tion and implies new functional differences between inte-
grin subgroups.
In this study, we show that integrin–tTG complexes are
formed inside the cell early during biosynthesis. We were
unable to reconstitute integrin interaction with tTG in
vitro using purified proteins, most likely because the for-
mation of these complexes involves some as-yet unidenti-
fied intracellular intermediate(s) (data not shown). These
facts might explain some previous data showing inability
of purified tTG added to cells to influence cell adhesion
and spreading (Jones et al., 1997). We also generated a
truncated tTG mutant tTG[D592-687] with the deleted
fourth (most COOH-terminal) domain and found that al-
though it retained enzymatic and Fn-binding activities, it
did not associate with integrins and was not transported to
the cell surface (data not shown). These results suggest
that integrins might be involved in transporting tTG to the
cell surface. Thus, the integrin–tTG interaction estab-
lished in this work may provide an explanation for the sur-
face localization of tTG reported previously (Martinez et al.,
1994; Aeschlimann et al., 1995; Verderio et al., 1998), and
consequently, for its effects on cell adhesion and spreading
(Gentile et al., 1992; Jones et al., 1997; Verderio et al.,
1998).
How does the integrin–tTG interaction promote cell ad-
hesion? Integrins are relatively low affinity receptors for
ECM proteins, including Fn. In contrast, tTG binds with
high affinity to Fn and its 42-kD fragment (Turner and Lo-
rand, 1989; Radek et al., 1993), and as shown here, forms
stable complexes with integrins. The presence of integrin-
bound tTG on the surface creates a possibility for cells to
use an additional binding site within Fn for the interaction
with integrins. This potentially doubles the number of sites
in the Fn matrix that cells can access in the process of ad-
hesion and spreading. If the Fn chains are fully extended,
as in the case of the fibrillar matrix (Dzamba and Peters,
1991), the tTG-binding site would be separated from the
RGD motif by .20 nm, minimizing steric restrictions
against their simultaneous occupation. Furthermore, the
tTG-binding site on integrins most likely involves se-
quences outside the integrin ligand-binding pocket, consis-Akimov et al. The Role of Tissue Transglutaminase in Cell Adhesion 837
tent with the fact that their association is not perturbed by
110-kD cell-binding Fn fragment or RGD-containing pep-
tides and function-blocking anti–b1 integrin antibodies
(data not shown). Therefore, two types of ternary adhe-
sion complexes can be envisioned as shown schematically
in Fig. 10. Cells can adhere to Fn via integrins in the ab-
sence of tTG (Fig. 10 A). In the simplest case, tTG serves
merely as a bridge between integrin and Fn (Fig. 10 B).
This alone could strengthen adhesion because of the
higher affinity and by allowing a second integrin molecule
to access the RGD site in the same Fn chain. However, be-
yond this is the possibility for even more stable ternary
complexes, where each protein interacts with two others
(Fig. 10 C). Either scenario should increase cell adhesion
and spreading on Fn. In agreement with the proposed
model, tTG promotes integrin clustering in the membrane,
and consequently, amplifies integrin outside-in signaling
(Fig. 9). Integrin clustering could be further facilitated if
tTG forms stable bivalent dimers, as does its homologue in
FXIIIa (Yee et al., 1994). It is also possible that binding to
tTG could affect the activation state of integrins.
Based on the interaction of tTG with several ECM pro-
teins reported previously (Bowness et al., 1987; Ach-
yuthan et al., 1988; Aeschlimann and Paulsson, 1991;
Aeschlimann et al., 1995) and the evidence presented here
that tTG associates with multiple integrins, the proposed
model is likely applicable to ECM proteins other than Fn.
tTG is widely expressed in vivo, but its physiological role
remains poorly understood. This study defines a function
for tTG in cell adhesion that is distinct from and inde-
pendent of its enzymatic (cross-linking) activity. How-
ever, this newly identified function could serve to concen-
trate transglutaminase activity at sites of adhesion and to
strengthen locally the ECM. Upregulation of integrin–tTG
association might be expected to occur when cells require
enhanced adhesion and anchoring to the underlying sub-
strate. This could take place during normal cell differentia-
tion and under certain pathological conditions involving
abnormal adhesion, such as tumor metastasis. Cell-modu-
lated association of tTG with integrins represents a novel
way to modify integrin adhesive function, in addition to
regulation of integrin expression and ligand-binding affin-
ity. Further studies will help to elucidate the physiological
significance of this interaction and mechanisms of its regu-
lation on the cellular level.
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